XBIT Stock Analysis: Buy, Sell, or Hold?
XBIT - XBiotech Inc
$2.27
-0.01 (-0.44%)
▼
5d:
+1.79%
30d:
-0.87%
90d:
-9.2%
BUY
HIGH Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 12, 2026
2d
Get Alerted When XBIT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: XBIT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: XBIT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: XBIT is currently trading at $2.27, which is considered fair relative to its 30-day fair value range of $2.24 to $2.33.
Technical Outlook: Technically, XBIT is in a downtrend. The price is currently testing key support at $2.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: XBIT scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.00 (+693.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XBIT is in a downtrend. The price is currently testing key support at $2.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: XBIT scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.00 (+693.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.24 -
$2.33
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 693.0% below Wall St target ($18.00)
- BULLISH: Bottoming setup score 75/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$2.24 -
$2.33
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.22
Resistance Level
$2.32
Current Trend
Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Wall Street Target
$18.00
(+693.0%)
Revenue Growth (YoY)
-93.3%
Share & Embed Analysis
Last updated: August 09, 2026 4:58 AM ET
Data refreshes hourly during market hours. Next update: 5:58 AM
Data refreshes hourly during market hours. Next update: 5:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 47 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 63 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 47 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 43 HOLD |
|
SMMT
Summit Therapeutics PLC |
STRONG BUY
10 analysts |
$28 | 67 BUY |
